+52.1%
JNJ vs MRNA
+485.7%
-433.6%
-11.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.3% | +5.4% | -5.7% | -0.3% |
| 7D | -3.5% | -1.1% | -2.4% | -3.5% |
| 30D | +2.3% | +126.1% | -123.8% | +1.5% |
| 3M | +12.0% | +190.0% | -178.0% | +10.8% |
| 6M | +10.5% | +157.2% | -146.8% | +9.5% |
| YTD | +30.4% | +388.2% | -357.8% | +26.2% |
| 1Y | +52.1% | +467.0% | -414.9% | +46.5% |
| All | +52.1% | +485.7% | -433.6% | +46.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling